Immuno-Oncology Solutions

Somatic Cancer Mutations Curation

The OncoMD platform integrates diverse genomics data from over 7,500 research publications powered by sophisticated software, bioinformatics and computational tools to drive exploratory research in cancer.

With over 2 million extensively annotated mutations, researchers can investigate cancer at a molecular level to discover novel drug targets, biomarkers of drug sensitivity/resistance and impact of mutations to predict responses to cancer immunotherapy drugs.

To understand more about our OncoMD platform reach us at or fill in the form below:

2023 © MedGenome • All Rights Reserved
Request a Quote